At the annual American Academy of Ophthalmology meeting in Chicago, Healio.com/OSN talked with key opinion leaders regarding important ophthalmic advances of the past year and up-and-coming topics.
Here are the top five most-viewed video perspectives from AAO:
Santen initiates phase 3 studies of omidenepag for glaucoma
Ellie Chabi, MD, the therapeutic area head for glaucoma and neuroprotection and the lead for artificial intelligence programs within global biomedical science at Santen, discusses the initiation of two phase 3 clinical trials of omidenepag isopropyl for the treatment of glaucoma
Uncategorized